Prescription drug · ANDA
Ciprofloxacin NDC 72189-623
Ciprofloxacin hydrochloride 500 mg/1 · Tablet · Oral · Direct_Rx
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72189-623-10 | 72189062310 | 10 TABLET in 1 BOTTLE (72189-623-10)Marketed from May 14, 2025 | |
| 72189-623-14 | 72189062314 | 14 TABLET in 1 BOTTLE (72189-623-14)Marketed from May 14, 2025 | |
| 72189-623-20 | 72189062320 | 20 TABLET in 1 BOTTLE (72189-623-20)Marketed from May 14, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ciprofloxacin
- Generic name (nonproprietary)
- ciprofloxacin
- Active ingredients
- Ciprofloxacin hydrochloride — 500 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Direct_Rx
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 208921
- Marketing start
- Listing expires
- Other FDA classes
- Cytochrome P450 1A2 Inhibitors (Mechanism)Fluoroquinolones (Chemical structure)
- Identifiers
- Product ID 72189-623_4c9a9248-b591-7e0a-e063-6394a90a884dSPL ID 4c9a9248-b591-7e0a-e063-6394a90a884dSPL set ID 351b41db-622f-a1eb-e063-6294a90a5667RxCUI 309309UNII 4BA73M5E37
- Pharmacologic class
- Fluoroquinolone Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472189062310followed by a unit qualifier and the quantityPackage 72189-0623-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Click here to enter Indications 1.1 Skin and Skin Structure Infections Ciprofloxacin tablets are indicated in adult patients for treatment of skin and skin structure infections caused by Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Proteus mirabilis, Proteus vulgaris, Providencia stuartii, Morganella morganii, Citrobacter freundii, Pseudomonas aeruginosa, methicillin-susceptible Staphylococcus aureus, methicillin-susceptible Staphylococcus epidermidis, or Streptococcus pyogenes. 1.2 Bone and Joint Infections Ciprofloxacin tablets are indicated in adult patients for treatment of bone and joint infections caused by Enterobacter cloacae, Serratia marcescens, or Pseudomonas aer…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 208921
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Ciprofloxacinciprofolxacin | Ciprofloxacin hydrochloride 250 mg/1 | TabletOral | Coupler LLC | 67046-1460 |
| Ciprofloxacinciprofolxacin | Ciprofloxacin hydrochloride 250 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 72789-519 |
| Ciprofloxacinciprofolxacin | Ciprofloxacin hydrochloride 500 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4229 |
| Ciprofloxacinciprofolxacin | Ciprofloxacin hydrochloride 500 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-3610 |
| Ciprofloxacin | Ciprofloxacin hydrochloride 500 mg/1 | Tablet, CoatedOral | St. Mary's Medical Park Pharmacy | 60760-676 |
| Ciprofloxacin | Ciprofloxacin hydrochloride 500 mg/1 | Tablet, CoatedOral | Northwind Health Company, LLC | 51655-490 |
| Ciprofloxacinciprofolxacin | Ciprofloxacin hydrochloride 250 mg/1 | TabletOral | Asclemed USA, Inc. | 76420-928 |
| Ciprofloxacinciprofolxacin | Ciprofloxacin hydrochloride 500 mg/1 | TabletOral | Proficient Rx LP | 82804-130 |
| Ciprofloxacinciprofolxacin | Ciprofloxacin hydrochloride 500 mg/1 | TabletOral | Asclemed USA, Inc. | 76420-929 |
| Ciprofloxacin | Ciprofloxacin hydrochloride 250 mg/1 | TabletOral | St. Mary's Medical Park Pharmacy | 60760-690 |
| Ciprofloxacinciprofolxacin | Ciprofloxacin hydrochloride 500 mg/1 | TabletOral | ST. MARY'S MEDICAL PARK PHARMACY | 60760-689 |
| Ciprofloxacinciprofolxacin | Ciprofloxacin hydrochloride 500 mg/1 | TabletOral | Redpharm Drug | 67296-2135 |
| Ciprofloxacin | Ciprofloxacin hydrochloride 250 mg/1 | Tablet, CoatedOral | Bryant Ranch Prepack | 71335-2097 |
| Ciprofloxacinciprofolxacin | Ciprofloxacin hydrochloride 250 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-3901 |
| Ciprofloxacin | Ciprofloxacin hydrochloride 250 mg/1 | Tablet, CoatedOral | Method Pharmaceuticals, LLC | 58657-675 |
| Ciprofloxacinciprofolxacin | Ciprofloxacin hydrochloride 500 mg/1 | TabletOral | Advanced Rx of Tennessee, LLC | 80425-0492 |
| Ciprofloxacin | Ciprofloxacin hydrochloride 500 mg/1 | Tablet, CoatedOral | Method Pharmaceuticals, LLC | 58657-676 |
| Ciprofloxacinciprofolxacin | Ciprofloxacin hydrochloride 250 mg/1 | TabletOral | Redpharm Drug | 67296-2169 |
| Ciprofloxacinciprofolxacin | Ciprofloxacin hydrochloride 500 mg/1 | TabletOral | Coupler LLC | 67046-1537 |
| Ciprofloxacin | Ciprofloxacin hydrochloride 250 mg/1 | Tablet, CoatedOral | Preferred Pharmaceuticals Inc. | 68788-8200 |
Showing 20 of 40.